A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

Nabil Mubarak,Rabab Gaafar,Samir Shehata,Tarek Hashem,Dani Abigeres,Hamdy A. Azim,Gamal El-Husseiny,Hamed AlHusaini,Zhixin Liu

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

2012

Nabil Mubarak
Rabab Gaafar
Samir Shehata
Tarek Hashem
Dani Abigeres
Hamdy A. Azim
Gamal El-Husseiny
Hamed AlHusaini
Zhixin Liu

Background Maintenance therapy for non-small cell lung cancer (NSCLC) aims to extend disease control after first-line chemotherapy with active and well-tolerated agents. The utility of continuation maintenance therapy requires further research.

Keywords:

Phases of clinical research
Pemetrexed
Pathology
Cisplatin
Disease
Surgical oncology
Maintenance therapy
Oncology
Lung cancer
Medicine
Chemotherapy
Internal medicine
Young adult

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations